Petlife Pharmaceuticals (PTLF) Financial Statements

1 Followers

Petlife Pharmaceuticals Financial Overview

Petlife Pharmaceuticals's market cap is currently $22.21K. The company's EPS TTM is $-0.03; its P/E ratio is ―; Petlife Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Aug 17
Income Statement
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Income	$ -22.66M
EBITDA	$ -22.87M
Net Income	$ -23.26M
Balance Sheet
Cash & Short-Term Investments	$ 54.25K
Total Assets	$ 55.00K
Total Debt	$ 717.18K
Net Debt	$ 662.92K
Total Liabilities	$ 1.44M
Stockholders' Equity	$ -1.38M
Cash Flow
Free Cash Flow	$ -318.92K
Operating Cash Flow	$ -318.92K
Investing Cash Flow	$ 0.00
Financing Cash Flow	$ 372.00K

Currency in USD

Petlife Pharmaceuticals Earnings and Revenue History

Income Statement >

Petlife Pharmaceuticals Debt to Assets

Balance Sheet >

Petlife Pharmaceuticals Cash Flow

Cash Flow >

Petlife Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >